Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dydrogesterone versus micronised vaginal progesterone for luteal phase support in assisted reproductive treatment
PACTR202504881516590Not yet recruiting
- Sponsor
- NWEZE SYLVESTER ONUEGBUNAM
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dydrogesterone and progesterone in female infertility (2 arms), sponsored by NWEZE SYLVESTER ONUEGBUNAM. Primary endpoint: Primary efficacy endpoint. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
female infertility
Beyond the preview
Go deeper on PACTR202504881516590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202504881516590.